Phase 3 study of Opdivo in head and neck cancer meets primary endpoint

Phase 3 study of Opdivo in head and neck cancer meets primary endpoint

http://pharminent.com/2016/01/29/phase-3-study-of-opdivo-in-head-and-neck-cancer-meets-primary-endpoint/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s